Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.
Saved in:
| Title: | Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. |
|---|---|
| Authors: | Colucci M; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Faculty of Biology and Medicine, University of Lausanne UNIL, CH1011 Lausanne, Switzerland., Zumerle S; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Bressan S; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Gianfanti F; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Troiani M; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Bioinformatics Core Unit, Swiss Institute of Bioinformatics, TI, Bellinzona, Switzerland., Valdata A; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland., D'Ambrosio M; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; MRC London Institute of Medical Sciences (LMS), London, UK., Pasquini E; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Varesi A; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Cogo F; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Mosole S; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Dongilli C; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Desbats MA; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Contu L; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Revankdar A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA., Chen J; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Kalathur M; Children's GMP, LLC, St. Jude Children's Research Hospital, 262 Danny Thomas Place Mail Stop 920 Memphis, TN 38105, USA., Perciato ML; School of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK., Basilotta R; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 viale Ferdinando D'Alcontres, Italy., Endre L; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland., Schauer S; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland., Othman A; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland., Guccini I; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland., Saponaro M; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Maraccani L; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Bancaro N; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Lai P; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Liu L; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Pernigoni N; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Mele F; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland., Merler S; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine, University of Verona and Verona University and Hospital Trust, Verona, Italy., Trotman LC; Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA., Guarda G; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland., Calì B; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Montopoli M; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Alimonti A; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. Electronic address: andrea.alimonti@ior.usi.ch. |
| Source: | Cancer cell [Cancer Cell] 2024 Apr 08; Vol. 42 (4), pp. 646-661.e9. Date of Electronic Publication: 2024 Feb 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38428412 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Colucci+M%22">Colucci M</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Faculty of Biology and Medicine, University of Lausanne UNIL, CH1011 Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zumerle+S%22">Zumerle S</searchLink>; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Bressan+S%22">Bressan S</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Gianfanti+F%22">Gianfanti F</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Troiani+M%22">Troiani M</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Bioinformatics Core Unit, Swiss Institute of Bioinformatics, TI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Valdata+A%22">Valdata A</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland.<br /><searchLink fieldCode="AU" term="%22D'Ambrosio+M%22">D'Ambrosio M</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; MRC London Institute of Medical Sciences (LMS), London, UK.<br /><searchLink fieldCode="AU" term="%22Pasquini+E%22">Pasquini E</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Varesi+A%22">Varesi A</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cogo+F%22">Cogo F</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mosole+S%22">Mosole S</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dongilli+C%22">Dongilli C</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Desbats+MA%22">Desbats MA</searchLink>; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Contu+L%22">Contu L</searchLink>; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Revankdar+A%22">Revankdar A</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.<br /><searchLink fieldCode="AU" term="%22Kalathur+M%22">Kalathur M</searchLink>; Children's GMP, LLC, St. Jude Children's Research Hospital, 262 Danny Thomas Place Mail Stop 920 Memphis, TN 38105, USA.<br /><searchLink fieldCode="AU" term="%22Perciato+ML%22">Perciato ML</searchLink>; School of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK.<br /><searchLink fieldCode="AU" term="%22Basilotta+R%22">Basilotta R</searchLink>; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 viale Ferdinando D'Alcontres, Italy.<br /><searchLink fieldCode="AU" term="%22Endre+L%22">Endre L</searchLink>; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schauer+S%22">Schauer S</searchLink>; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland.<br /><searchLink fieldCode="AU" term="%22Othman+A%22">Othman A</searchLink>; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland.<br /><searchLink fieldCode="AU" term="%22Guccini+I%22">Guccini I</searchLink>; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland.<br /><searchLink fieldCode="AU" term="%22Saponaro+M%22">Saponaro M</searchLink>; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Maraccani+L%22">Maraccani L</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Bancaro+N%22">Bancaro N</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lai+P%22">Lai P</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liu+L%22">Liu L</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pernigoni+N%22">Pernigoni N</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mele+F%22">Mele F</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Merler+S%22">Merler S</searchLink>; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine, University of Verona and Verona University and Hospital Trust, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Trotman+LC%22">Trotman LC</searchLink>; Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA.<br /><searchLink fieldCode="AU" term="%22Guarda+G%22">Guarda G</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Calì+B%22">Calì B</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Montopoli+M%22">Montopoli M</searchLink>; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Alimonti+A%22">Alimonti A</searchLink>; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. Electronic address: andrea.alimonti@ior.usi.ch. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130617%22">Cancer cell</searchLink> [Cancer Cell] 2024 Apr 08; Vol. 42 (4), pp. 646-661.e9. <i>Date of Electronic Publication: </i>2024 Feb 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130617 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-3686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215356108%22">15356108 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Cell <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38428412 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ccell.2024.02.004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 646 Titles: – TitleFull: Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Colucci M – PersonEntity: Name: NameFull: Zumerle S – PersonEntity: Name: NameFull: Bressan S – PersonEntity: Name: NameFull: Gianfanti F – PersonEntity: Name: NameFull: Troiani M – PersonEntity: Name: NameFull: Valdata A – PersonEntity: Name: NameFull: D'Ambrosio M – PersonEntity: Name: NameFull: Pasquini E – PersonEntity: Name: NameFull: Varesi A – PersonEntity: Name: NameFull: Cogo F – PersonEntity: Name: NameFull: Mosole S – PersonEntity: Name: NameFull: Dongilli C – PersonEntity: Name: NameFull: Desbats MA – PersonEntity: Name: NameFull: Contu L – PersonEntity: Name: NameFull: Revankdar A – PersonEntity: Name: NameFull: Chen J – PersonEntity: Name: NameFull: Kalathur M – PersonEntity: Name: NameFull: Perciato ML – PersonEntity: Name: NameFull: Basilotta R – PersonEntity: Name: NameFull: Endre L – PersonEntity: Name: NameFull: Schauer S – PersonEntity: Name: NameFull: Othman A – PersonEntity: Name: NameFull: Guccini I – PersonEntity: Name: NameFull: Saponaro M – PersonEntity: Name: NameFull: Maraccani L – PersonEntity: Name: NameFull: Bancaro N – PersonEntity: Name: NameFull: Lai P – PersonEntity: Name: NameFull: Liu L – PersonEntity: Name: NameFull: Pernigoni N – PersonEntity: Name: NameFull: Mele F – PersonEntity: Name: NameFull: Merler S – PersonEntity: Name: NameFull: Trotman LC – PersonEntity: Name: NameFull: Guarda G – PersonEntity: Name: NameFull: Calì B – PersonEntity: Name: NameFull: Montopoli M – PersonEntity: Name: NameFull: Alimonti A IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 04 Text: 2024 Apr 08 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1878-3686 Numbering: – Type: volume Value: 42 – Type: issue Value: 4 Titles: – TitleFull: Cancer cell Type: main |
| ResultId | 1 |